Axon Enterprise, Inc. (AXON) Stock Analysis
Latest ClaritX AI analysis ·
Axon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software. These solutions are designed to equ
| Metric | Value |
|---|---|
| Price | $413.35 |
| Market cap | $33.3B |
| Sector | Industrials |
| Industry | Aerospace & Defense |
| ClaritX AI score | 28/100 |
| Price/Book | 9.04 |
| Beta | 1.40 |
AI verdict
Axon Enterprise (AXON) presents a fascinating paradox for investors, characterized by exceptional fundamental execution that is aggressively countered by severely degraded technical sentiment and extreme valuations. Currently trading at $413.35, the asset is stationed a brutal 45.9% below its 52-week euphoric high of $764.02. Evaluating a stock trading this deeply below its peak requires recognizing that it presents a vastly different risk dynamic than one consolidating near fresh highs; it is heavily burdened by a colossal wall of underwater supply as trapped investors desperately seek to exit into any relief bounces. Compounding this structural danger is the stock's elevated beta of 1.399, which actively amplifies broader market volatility by nearly 40%, completely stripping away the defensive characteristics typically expected from its Aerospace & Defense sector classification. Despite boasting near-60% gross margins and an impenetrable monopoly in global law enforcement technology infrastructure, the stock remains highly vulnerable to multiple compression. It commands an extreme 166.53x trailing earnings multiple, granting investors virtually zero margin of safety. While the fundamental trajectory remains incredibly strong—highlighted by 35% revenue growth and a brilliant $1 billion 0% convertible debt raise—the technicals are undeniably broken, with the RSI plunging to 25.76. Until Axon decisively reclaims its critical 200-day moving average of $496.96 on heavy institut
What this score has been worth
ClaritX scores AXON 28 out of 100 (snapshot 2026-10-05).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 117 analyses that scored in the 0-49 band, the average forward return was -4.2% with a 32% win rate, -9.0pp against the S&P 500. That is a measured tendency across many names, not a forecast for AXON — roughly 68% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.